Royal Philips has received the US Food and Drug Administration (FDA) 510(k) approval for its motorised image-guided therapy mobile C-arm system 9000 (Zenition 90 motorised).

Zenition 90 system is designed with expanded capabilities to deliver advanced image quality for the most challenging procedures and help clinicians deliver high-quality care to more patients.

The new mobile C-arm will help address complex vascular needs and a range of clinical procedures such as cardiac interventions, pain management and urology.

Philips used its EcoDesign process for the Zenition 90 Motorised, as part of its sustainability commitments, to improve product life by 25% and power efficiency by 13%.

The medical technology company is also offering the image-guided therapy mobile C-arm system with a non-motorised configuration.

Philips image-guided therapy systems business leader Mark Stoffels said: “During complex procedures, it’s vital to be able to rely on surgical imaging systems.

“As clinicians navigate their way through challenging anatomy, the priority is to quickly visualize small anatomical details while limiting X-ray dose.

“The new Zenition 90 Motorized empowers medical teams to confidently perform a wide range of interventions while achieving the best possible outcome for their patients.”

Philips said that its Zenition Image-Guided Therapy Mobile C-arm Systems Bring together advances in image capture and processing and versatility, developed on the Azurion platform.

Zenition 90 is an intuitive C-arm system that is motorised and fast and allows clinicians to control it from the table-side with more flexibility and independence.

It delivers superior image quality for the most challenging procedures and is designed to address complex procedural needs, said the health technology company.

The system allows greater clinical efficiency thanks to its automated workflows, the image controls via the Touch Screen Module and the advanced software solutions.

Clinicians from the US and EU used the Zenition 90 Motorised in simulated environments, as part of independent hands-on usability studies.

In the studies, all users said that they have complete control over C-arm movements and 97% reported that workflow features will help save time during procedures, said Philips.